SG11202011691PA - Small molecule inhibitors of the jak family of kinases - Google Patents
Small molecule inhibitors of the jak family of kinasesInfo
- Publication number
- SG11202011691PA SG11202011691PA SG11202011691PA SG11202011691PA SG11202011691PA SG 11202011691P A SG11202011691P A SG 11202011691PA SG 11202011691P A SG11202011691P A SG 11202011691PA SG 11202011691P A SG11202011691P A SG 11202011691PA SG 11202011691P A SG11202011691P A SG 11202011691PA
- Authority
- SG
- Singapore
- Prior art keywords
- kinases
- small molecule
- molecule inhibitors
- jak family
- jak
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862685737P | 2018-06-15 | 2018-06-15 | |
US201962846290P | 2019-05-10 | 2019-05-10 | |
PCT/IB2019/055005 WO2019239387A1 (fr) | 2018-06-15 | 2019-06-14 | Inhibiteurs à petites molécules de la famille jak de kinases |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202011691PA true SG11202011691PA (en) | 2020-12-30 |
Family
ID=67766195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202011691PA SG11202011691PA (en) | 2018-06-15 | 2019-06-14 | Small molecule inhibitors of the jak family of kinases |
Country Status (23)
Country | Link |
---|---|
US (3) | US20200017498A1 (fr) |
EP (1) | EP3807277A1 (fr) |
JP (1) | JP2021528391A (fr) |
KR (1) | KR20210021342A (fr) |
CN (1) | CN112313233A (fr) |
AU (1) | AU2019286641A1 (fr) |
BR (1) | BR112020024744A2 (fr) |
CA (1) | CA3101438A1 (fr) |
CL (1) | CL2020003227A1 (fr) |
CO (1) | CO2020015396A2 (fr) |
CR (1) | CR20200603A (fr) |
EC (1) | ECSP20080817A (fr) |
IL (1) | IL279314A (fr) |
JO (1) | JOP20200311A1 (fr) |
MA (1) | MA52900A (fr) |
MX (1) | MX2020013688A (fr) |
NI (1) | NI202000100A (fr) |
PE (1) | PE20212113A1 (fr) |
PH (1) | PH12020551984A1 (fr) |
SG (1) | SG11202011691PA (fr) |
TW (1) | TW202016110A (fr) |
UY (1) | UY38262A (fr) |
WO (1) | WO2019239387A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
AU2017377069B2 (en) | 2016-12-16 | 2020-07-23 | Janssen Pharmaceutica Nv | Small molecule inhibitors of the JAK family of kinases |
TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Jak激酶家族之小分子抑制劑 |
JP2024509587A (ja) * | 2021-03-11 | 2024-03-04 | ヤンセン ファーマシューティカ エヌ.ベー. | Jak媒介性障害の治療に使用するためのlorpucitinib |
CN113292561A (zh) * | 2021-05-22 | 2021-08-24 | 中国药科大学 | 一种二吡咯并吡啶结构的化合物、制备方法和医药用途 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080747A (en) | 1999-03-05 | 2000-06-27 | Hughes Institute | JAK-3 inhibitors for treating allergic disorders |
PE20010044A1 (es) | 1999-04-23 | 2001-03-10 | Smithkline Beecham Plc | Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona |
AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
EP1509524B1 (fr) | 2002-05-31 | 2008-03-26 | Schering Corporation | Polymorphes d'un inhibiteur v de xanthine phosphodiesterase |
GB0319935D0 (en) | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
US7737279B2 (en) | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
WO2007005462A1 (fr) | 2005-07-01 | 2007-01-11 | Wyeth | Formes cristallines de 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile, et leurs procedes de preparation |
EP2251341A1 (fr) | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Hétérocycles inhibiteurs de Janus kinase-3 |
JP5071374B2 (ja) | 2005-07-14 | 2012-11-14 | アステラス製薬株式会社 | ヘテロ環ヤヌスキナーゼ3阻害剤 |
PE20140407A1 (es) | 2008-06-10 | 2014-04-25 | Abbott Lab | Nuevos compuestos triciclicos |
US8426411B2 (en) | 2008-06-10 | 2013-04-23 | Abbott Laboratories | Tricyclic compounds |
MX2012002480A (es) | 2009-09-03 | 2012-03-26 | Bristol Myers Squibb Co | Inhibidores de jak2 y su uso en el tratamiento de enfermedades mieloproliferativas y cancer. |
RU2012127368A (ru) | 2009-12-01 | 2014-01-10 | Эбботт Лэборетриз | Новые трициклические соединения |
MX2012008049A (es) | 2010-01-12 | 2012-08-01 | Hoffmann La Roche | Compuestos heterociclicos triciclicos, composiciones y metodos de uso de los mismos,. |
CA2789186A1 (fr) | 2010-02-10 | 2011-08-18 | Genon Biotechnologies Oy | Domaines kinase a double activite et leurs utilisations |
WO2013007765A1 (fr) * | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Composés tricycliques fusionnés utilisés en tant qu'inhibiteurs des janus kinases |
GB201212081D0 (en) | 2012-07-06 | 2012-08-22 | Kalvista Pharmaceuticals Ltd | New polymorph |
WO2014123167A1 (fr) | 2013-02-08 | 2014-08-14 | 日産化学工業株式会社 | Composé pyrrolopyridine tricyclique et inhibiteur de jak |
EP2924026A1 (fr) | 2014-03-28 | 2015-09-30 | Novartis Tiergesundheit AG | Aminosulfonylméthylcyclohexanes comme inhibiteurs de JAK |
NZ725001A (en) | 2014-05-14 | 2021-08-27 | Nissan Chemical Ind Ltd | Tricyclic compound and jak inhibitor |
AU2016267141B2 (en) | 2015-05-28 | 2020-04-16 | Theravance Biopharma R&D Ip, Llc | Naphthyridine compounds as jak kinase inhibitors |
US20180321235A1 (en) | 2015-11-04 | 2018-11-08 | Mayo Foundation For Medical Education And Research | Methods and materials for treating autoimmune conditions |
JOP20190053A1 (ar) | 2016-09-23 | 2019-03-21 | Novartis Ag | مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط |
HRP20220255T1 (hr) | 2016-10-24 | 2022-04-29 | Astrazeneca Ab | Derivati 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f]izokinolina koji su korisni u liječenju raka |
PT3555105T (pt) | 2016-12-16 | 2020-12-21 | Lilly Co Eli | Compostos de 7-feniletilamino-4h-pirimido[4,5-d][1,3]oxazin-2-ona como inibidores de idh1 e idh2 mutantes |
HUE060533T2 (hu) | 2016-12-16 | 2023-03-28 | Pfizer | GLP-1 receptor agonisták és alkalmazásuk |
EP3555050A1 (fr) | 2016-12-16 | 2019-10-23 | Basf Se | Composés pesticides |
AU2017377069B2 (en) | 2016-12-16 | 2020-07-23 | Janssen Pharmaceutica Nv | Small molecule inhibitors of the JAK family of kinases |
EP3528645A1 (fr) | 2016-12-16 | 2019-08-28 | Société des Produits Nestlé S.A. | Oligosaccharides pour la génération d'arômes |
JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
DK3568396T3 (da) | 2017-01-11 | 2021-01-18 | Leo Pharma As | Hidtil ukendte amino-imidazopyridinderivater som janus kinase-inhibitorer og farmaceutisk anvendelse deraf |
LT3494116T (lt) | 2017-01-30 | 2020-01-10 | Astrazeneca Ab | Estrogeno receptorių moduliatoriai |
MX2019012431A (es) | 2017-04-21 | 2020-08-03 | Ikena Oncology Inc | Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos. |
TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Jak激酶家族之小分子抑制劑 |
WO2020216936A1 (fr) | 2019-04-24 | 2020-10-29 | Janssen Pharmaceutica Nv | Formulations liquides non cliniques d'inhibiteur pan-jak |
-
2019
- 2019-06-13 TW TW108120432A patent/TW202016110A/zh unknown
- 2019-06-14 SG SG11202011691PA patent/SG11202011691PA/en unknown
- 2019-06-14 EP EP19759032.6A patent/EP3807277A1/fr active Pending
- 2019-06-14 PE PE2020001995A patent/PE20212113A1/es unknown
- 2019-06-14 MX MX2020013688A patent/MX2020013688A/es unknown
- 2019-06-14 AU AU2019286641A patent/AU2019286641A1/en active Pending
- 2019-06-14 KR KR1020217000012A patent/KR20210021342A/ko not_active Application Discontinuation
- 2019-06-14 CR CR20200603A patent/CR20200603A/es unknown
- 2019-06-14 JP JP2020569049A patent/JP2021528391A/ja active Pending
- 2019-06-14 MA MA052900A patent/MA52900A/fr unknown
- 2019-06-14 CA CA3101438A patent/CA3101438A1/fr active Pending
- 2019-06-14 CN CN201980040198.7A patent/CN112313233A/zh active Pending
- 2019-06-14 WO PCT/IB2019/055005 patent/WO2019239387A1/fr active Application Filing
- 2019-06-14 UY UY0001038262A patent/UY38262A/es unknown
- 2019-06-14 BR BR112020024744-8A patent/BR112020024744A2/pt not_active Application Discontinuation
- 2019-06-14 JO JOP/2020/0311A patent/JOP20200311A1/ar unknown
- 2019-09-24 US US16/581,081 patent/US20200017498A1/en not_active Abandoned
-
2020
- 2020-01-29 US US16/776,243 patent/US11066406B2/en active Active
- 2020-11-19 PH PH12020551984A patent/PH12020551984A1/en unknown
- 2020-12-09 IL IL279314A patent/IL279314A/en unknown
- 2020-12-09 CO CONC2020/0015396A patent/CO2020015396A2/es unknown
- 2020-12-11 NI NI202000100A patent/NI202000100A/es unknown
- 2020-12-11 CL CL2020003227A patent/CL2020003227A1/es unknown
- 2020-12-14 EC ECSENADI202080817A patent/ECSP20080817A/es unknown
-
2021
- 2021-07-15 US US17/377,249 patent/US11787807B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MA52900A (fr) | 2021-04-21 |
UY38262A (es) | 2019-12-31 |
BR112020024744A2 (pt) | 2021-03-23 |
TW202016110A (zh) | 2020-05-01 |
CR20200603A (es) | 2021-01-20 |
CN112313233A (zh) | 2021-02-02 |
CO2020015396A2 (es) | 2021-03-08 |
PE20212113A1 (es) | 2021-11-04 |
AU2019286641A1 (en) | 2020-12-10 |
US20200165250A1 (en) | 2020-05-28 |
PH12020551984A1 (en) | 2021-08-02 |
NI202000100A (es) | 2021-06-30 |
KR20210021342A (ko) | 2021-02-25 |
CA3101438A1 (fr) | 2019-12-19 |
ECSP20080817A (es) | 2021-01-29 |
WO2019239387A1 (fr) | 2019-12-19 |
US20200017498A1 (en) | 2020-01-16 |
JP2021528391A (ja) | 2021-10-21 |
CL2020003227A1 (es) | 2021-05-14 |
MX2020013688A (es) | 2021-02-26 |
US11787807B2 (en) | 2023-10-17 |
IL279314A (en) | 2021-01-31 |
EP3807277A1 (fr) | 2021-04-21 |
JOP20200311A1 (ar) | 2020-11-30 |
US20210340144A1 (en) | 2021-11-04 |
US11066406B2 (en) | 2021-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201904615B (en) | Small molecule inhibitors of the jak family of kinases | |
IL267215A (en) | Imidazopyrrolopyridines as inhibitors of the jak family of kinases | |
IL287136B1 (en) | Receptor inhibitors - interacting with protein kinase 1 | |
IL279314A (en) | Small molecule inhibitors of the JAK family of kinases | |
EP3247692A4 (fr) | Inhibiteurs de trka kinase | |
ZA201807179B (en) | Pyrimidine compounds as jak kinase inhibitors | |
IL274037A (en) | A pyrimidine compound as a JAK kinase inhibitor | |
SG11202002947TA (en) | Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same | |
IL276269A (en) | Aminopyrrolotriazines as kinase inhibitors | |
HUE044240T2 (hu) | Janus kináz (JAK) inhibitorok | |
IL280950A (en) | KEAP1-NRF2 protein-protein interaction inhibitors | |
HK1257555A1 (zh) | Tec激酶家族之抑制劑 | |
EP3376870A4 (fr) | Procédé de préparation d'inhibiteurs de kinase et de leurs intermédiaires | |
ZA202000107B (en) | Aminothiazole compounds as protein kinase inhibitors | |
EP3768272A4 (fr) | Inhibiteurs de jak | |
IL276312A (en) | Use of Alkoxypyrazoles as nitrification inhibitors | |
IL283885A (en) | cxcr7 inhibitors for cancer therapy | |
ZA202105399B (en) | Use of spiropidion | |
SG11202105136WA (en) | Application of chidamide | |
MA50430A (fr) | Inhibiteurs à petites molécules de la famille jak des kinases | |
PL3511335T3 (pl) | Wytwarzanie metalosilseskwioksanów | |
EP3446689A4 (fr) | Utilisation de composés d'isothiocyanate |